Key points: A once hotly anticipated EV truck maker, things have taken a turn for the worse for RIDE Ex-CEO sells $13M of shares, followed by GM's total $75M stake Th

Key points: Morgan Stanley argue INTC stock is likely to move sideways for the coming years The market offers higher growth opportunities from rising tech INTC stock

Key points: Customers are left enfuriated after widespread pre-oder price hikes Preorder numbers might be dubious following customer cancellations Rivian amongst othe

Key points: Tonix Pharma shares soared 58.2% after being granted orphan drug designation. The biotech company is developing a treatment for Prader-Willi syndrome in adults.

Key points: Snowflake shares crashed 21.8% on weak FY23 revenue growth forecasts. Investors ignored the company’s upbeat Q4 revenues to focus on guidance. Like most

Key points: Popular retailer misses earnings expectations for popular Q4 holiday period BBY stock rallied as much as 10% in Thursday premarket trading following promising outlook

Key points: Kiromic Bio stock price rallied 38.8% despite the lack of announcements. The shares came under significant buying pressure to cross the $1 mark. However,

Key points: Natwest shares have fallen 11.3% in one month amid selling pressure. However, the bank’s fundamentals remain strong as operating condit

Key points: RBC has upgraded Biogen to outperfor This follows the 50% stock price fall following the Aduhelm saga Is this from RBC just about the current price?

Key points: Darktrace shares surged 19.7% on upbeat six months results. The company finally cut ties with Mike Lynch, and its business is gaining. Moreover, there se

Key points: Morses Club Announces its perfectly decent doorstep lending business An increase in business, profits being made, what’s the problem? But is Morses Club going

Key points: Europa Oil had an agreement to pick up a gas field possibility That was cancelled, so what next? Obviously, fundraise for the next opportunity

Key points: Synairgen share rallied 42% despite the US NIH pausing its phase 3 trial. The firm is at risk of losing the US NIH’s partnership on its in-home trial. Howe

Key points: Greatland Gold is up 7% this morning Greatland has clarified results of the Havieron drilling These are what matter, not what Newcrest was reporting

Key points: Ford shares rallied 7.5% after announcing a massive reorganisation. The company is now split into three separate divisions to focus on EVs. Many are hopi

Key points: The Paysafe share price rose 15.6% after its Q4 results beat estimates. The payments company faces stiff competition from new entrants. Therefore, it has

Key points: SoFi Technologies share price soared 16.2% premarket on upbeat Q4 results. Investors expressed their confidence in the fintech company’s future outlook. Howeve

Key points: Dollar Tree reports fourth quarter earnings EPS beats analyst estimates but revenue misses Dollar Tree shares fall 3% following the report

Key points: Vistry shares surged 8.26% on upbeat FY 2021 results and FY 2022 guidance. The homebuilder has experienced strong demand for its homes and partnerships. In add

Key points: Hookipa Pharma stock has dropped 15% premarket This is a result of a stock offering Is this the outcome of the Gilead agreement reworking?